Design of vaccine efficacy trials for priority emerging and epidemic diseases

Design of vaccine efficacy trials for priority emerging and epidemic diseases

This item was presented at the 5th International Clinical Trials Methodology Conference (ICTMC 2019), Brighton, UK, September 2019.

Bibliographic Details
Main Authors:	Watson, C, Ferguson, N, Donnelly, C, Keeling, M, Tildesley, M, Horby, P, Edmunds, J
Format:	Conference item
Language:	English
Published:	BioMed Central 2019

Similar Items

Design of vaccine efficacy trials during public health emergencies
by: Dean, N, et al.
Published: (2019)

Choices in vaccine trial design in epidemics of emerging infections.
by: Rebecca Kahn, et al.
Published: (2018-08-01)

Core minimal datasets to advance clinical research for priority epidemic diseases
by: Rojek, AM, et al.
Published: (2019)

Chemoprophlaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations
by: Manoharan, L, et al.
Published: (2021)

Quantifying the value of perfect information in emergency vaccination campaigns
by: Bradbury, N, et al.
Published: (2017)

Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates
by: Williams, LR, et al.
Published: (2021)

Priority actions for addressing the obesity epidemic in England
by: Watson, F, et al.
Published: (2017)

Performance of different clinical trial designs to evaluate treatments during an epidemic
by: Brueckner, M, et al.
Published: (2018)

International biological reference preparations for emerging infectious diseases: vital tools in epidemic preparedness
by: Rampling, T, et al.
Published: (2018)

UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments
by: Noad, RJ, et al.
Published: (2019)

Quantifying the Value of Perfect Information in Emergency Vaccination Campaigns.
by: Naomi V Bradbury, et al.
Published: (2017-02-01)

Modelling livestock infectious disease control policy under differing social perspectives on vaccination behaviour.
by: Edward M Hill, et al.
Published: (2022-07-01)

GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic.
by: Whitehead, J, et al.
Published: (2017)

GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic.
by: John Whitehead, et al.
Published: (2017-03-01)

Topographic determinants of foot and mouth disease transmission in the UK 2001 epidemic
by: Keeling Matthew J, et al.
Published: (2006-01-01)

Measuring the efficacy of a vaccine during an epidemic
by: Antonio Scala, et al.
Published: (2023-01-01)

Measuring the efficacy of a vaccine during an epidemic.
by: Antonio Scala, et al.
Published: (2023-01-01)

Real-time decision-making during emergency disease outbreaks
by: Probert, W, et al.
Published: (2018)

Correction: GOST: A generic ordinal sequential trial design for a treatment trial in an emerging pandemic.
by: John Whitehead, et al.
Published: (2018-04-01)

Communicating uncertainty in epidemic models
by: McCabe, R, et al.
Published: (2021)

Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling study
by: Tildesley, MJ, et al.
Published: (2022)

International biological reference preparations for epidemic infectious diseases
by: Rampling, T, et al.
Published: (2019)

A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats
by: Longini, IM, et al.
Published: (2022)

Variant Creutzfeldt-Jakob disease: an unfolding epidemic of misfolded proteins.
by: Horby, P
Published: (2002)

Modernising epidemic science: enabling patient-centred research during epidemics
by: Rojek, A, et al.
Published: (2016)

Modelling optimal vaccination strategy for SARS-CoV-2 in the UK.
by: Sam Moore, et al.
Published: (2021-05-01)

Disease prevention versus data privacy: using landcover maps to inform spatial epidemic models.
by: Michael J Tildesley, et al.
Published: (2012-01-01)

Current issues of anti-epidemic readiness of a Russian Federation region for emergency situations associated with infectious diseases dangerous for humans. Report 2. Priority directions of anti-epidemic readiness
by: A. K. Noskov, et al.
Published: (2013-09-01)

Research Priorities to End the Adolescent HIV Epidemic in the United States: Viewpoint
by: Fernandez, M Isabel, et al.
Published: (2021-01-01)

The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England
by: Matt J. Keeling, et al.
Published: (2023-02-01)

Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections
by: Rojek, A, et al.
Published: (2017)

Effects of Vaccination Efficacy on Wealth Distribution in Kinetic Epidemic Models
by: Emanuele Bernardi, et al.
Published: (2022-01-01)

Communicating uncertainty in epidemic models
by: Ruth McCabe, et al.
Published: (2021-12-01)

Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone
by: Camacho, A, et al.
Published: (2016)

International Biological Reference Preparations for Epidemic Infectious Diseases
by: Tommy Rampling, et al.
Published: (2019-02-01)

Systematic selection between age and household structure for models aimed at emerging epidemic predictions
by: Pellis, L, et al.
Published: (2020)

Designing tuberculosis vaccine efficacy trials – lessons from recent studies
by: Ann M. Ginsberg
Published: (2019-05-01)

Marburg virus disease: the paradox of Nigeria’s preparedness and priority effects in co-epidemics
by: Rine Christopher Reuben, et al.
Published: (2023-01-01)

Emerging Priorities for Microbiome Research
by: Chad M. Cullen, et al.
Published: (2020-02-01)

Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review
by: Sigfrid, L, et al.
Published: (2020)